SARS

SARS siARRAY gene set launched

Published in TB and Outbreaks Week, June 24th, 2003

Dharmacon, Inc., announced that the company has launched SARS siARRAY Gene Set, a library of short interfering RNA (siRNA) duplexes targeted against multiple regions of the coronavirus that is believed to cause SARS.

RNA-interference is a powerful new tool used by genetic researchers to knock down, or silence, specific genes in order to assess their function. Use of Dharmacon's SARS siARRAY Gene Set enables researchers to study the life cycle and pathogenicity of the virus and to potentially facilitate development of therapeutics and vaccines against SARS. Previous studies have demonstrated that siRNAs have the potential to serve as antivirals, preventing infection of...

Want to see the full article?

Purchase this article for only $3.00

We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.

Welcome to NewsRx!

Learn more about a six-week, no-risk free trial of TB and Outbreaks Week

Source: TB and Outbreaks Week (2003-06-24)

NewsRx is Social

Top Medical Newsletters

Awards

Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005

Facts & Stats

NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.

Google 2010 PageRank: #2 Among Top Health News and Media Publications
Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry